메뉴 건너뛰기




Volumn , Issue , 2005, Pages 31-58

Phase I and phase I/II dose finding algorithms using continual reassessment method

Author keywords

[No Author keywords available]

Indexed keywords


EID: 85123815727     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (5)

References (38)
  • 1
    • 0032581450 scopus 로고    scopus 로고
    • An evaluation of phase I cancer clinical trial designs
    • Ahn, C. (1998) An evaluation of phase I cancer clinical trial designs. Stat. in Med., 17, 1537-19.
    • (1998) Stat. in Med , vol.17 , pp. 1537-1519
    • Ahn, C.1
  • 2
    • 2642664485 scopus 로고
    • The application of stochastic methods to the bioassay problem
    • Anbar, D. (1977) The application of stochastic methods to the bioassay problem. J. Statist. Planning Inference, 1, 191-206.
    • (1977) J. Statist. Planning Inference , vol.1 , pp. 191-206
    • Anbar, D.1
  • 3
    • 0011665245 scopus 로고
    • A stochastic Newton-Raphson method
    • Anbar, D. (1978) A stochastic Newton-Raphson method. J. Statist. Planning Inference, 2, 153-63.
    • (1978) J. Statist. Planning Inference , vol.2 , pp. 153-163
    • Anbar, D.1
  • 4
    • 0005499775 scopus 로고
    • Stochastic approximation methods and their use in bioassay and phase I clinical trials
    • Anbar, D. (1984) Stochastic approximation methods and their use in bioassay and phase I clinical trials. Commun. Statist., 13, 2451-2467.
    • (1984) Commun. Statist , vol.13 , pp. 2451-2467
    • Anbar, D.1
  • 5
    • 0031920799 scopus 로고    scopus 로고
    • Cancer phase I clinical trials: Efficient dose escalation with overdose control
    • Babb J., Rogatko A., and Zacks S. (1998) Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat. in Med., 17, 1103-20.
    • (1998) Stat. in Med , vol.17 , pp. 1103-1120
    • Babb, J.1    Rogatko, A.2    Zacks, S.3
  • 6
    • 0027319907 scopus 로고
    • The continual reassessment method in cancer phase I clinical trials: A simulation study
    • Chevret, S. (1993) The continual reassessment method in cancer phase I clinical trials: a simulation study. Stat. in Med., 12, 1093-1108.
    • (1993) Stat. in Med , vol.12 , pp. 1093-1108
    • Chevret, S.1
  • 7
    • 0028060511 scopus 로고
    • Practical modifications of the continual reassessment method for phase I cancer clinical trials
    • Faries, D. (1994) Practical modifications of the continual reassessment method for phase I cancer clinical trials. J. Biopharm. Statist., 4, 147-64.
    • (1994) J. Biopharm. Statist , vol.4 , pp. 147-164
    • Faries, D.1
  • 8
    • 0026663871 scopus 로고
    • Bayesian methods for phase I clnical trials
    • Gatsonis, C. and Greenhouse, J.B. (1992) Bayesian methods for phase I clnical trials. Stat. in Med., 11, 1377-1389.
    • (1992) Stat. in Med , vol.11 , pp. 1377-1389
    • Gatsonis, C.1    Greenhouse, J.B.2
  • 9
    • 0029027770 scopus 로고
    • Some practical improvements in the continual reassessment method for phase I studies
    • Goodman, S., Zahurak, M.L., and Piantadosi, S. (1995) Some practical improvements in the continual reassessment method for phase I studies. Stat. in Med., 14, 1149-61.
    • (1995) Stat. in Med , vol.14 , pp. 1149-1161
    • Goodman, S.1    Zahurak, M.L.2    Piantadosi, S.3
  • 10
    • 0027949027 scopus 로고
    • Simulation as a design tool for phase I/II clinical trials. An example from bone marrow transplantation
    • Gooley, T.A., Martin, P.J., Fisher, L.D., and Pettinger, M. (1994) Simulation as a design tool for phase I/II clinical trials. An example from bone marrow transplantation. Controlled Clin. Trials. 15, 450-62.
    • (1994) Controlled Clin. Trials , vol.15 , pp. 450-462
    • Gooley, T.A.1    Martin, P.J.2    Fisher, L.D.3    Pettinger, M.4
  • 11
    • 0000250624 scopus 로고
    • The behavior of maximum likelihood estimates under nonstandard conditions
    • Huber, P.J. (1967) The behavior of maximum likelihood estimates under nonstandard conditions. Proc. 6th Berkeley Symp., 1, 221-233.
    • (1967) Proc. 6th Berkeley Symp , vol.1 , pp. 221-233
    • Huber, P.J.1
  • 12
    • 85123815374 scopus 로고    scopus 로고
    • A new dose-finding design for bivariate outcomes
    • Ivanova, A. (2003) A new dose-finding design for bivariate outcomes. Biometrics 57, 1018-29.
    • (2003) Biometrics , vol.57 , pp. 1018-1029
    • Ivanova, A.1
  • 14
    • 0027499297 scopus 로고
    • Model-guided determination of maximum tolerated dose in phase I clinical trials: Evidence for increased precision
    • Mick, R. and Ratain, M.J. (1993) Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precision. J.Natl. Cancer Inst., 85, 217-223.
    • (1993) J.Natl. Cancer Inst , vol.85 , pp. 217-223
    • Mick, R.1    Ratain, M.J.2
  • 15
    • 0029001313 scopus 로고
    • An extension of the continual reassessment method using a preliminary up and down design in a dose finding study in cancer patients in order to investigate a greater number of dose levels
    • Moller, S. (1995) An extension of the continual reassessment method using a preliminary up and down design in a dose finding study in cancer patients in order to investigate a greater number of dose levels. Stat. in Med., 14, 911-22.
    • (1995) Stat. in Med , vol.14 , pp. 911-922
    • Moller, S.1
  • 16
    • 0037614842 scopus 로고    scopus 로고
    • Interval estimates of the probability of toxicity at the maximum tolerated dose for small samples
    • Natarajan, L. and O'Quigley J. (2003) Interval estimates of the probability of toxicity at the maximum tolerated dose for small samples. Stat. in Med., 22, 1829-36.
    • (2003) Stat. in Med , vol.22 , pp. 1829-1836
    • Natarajan, L.1    O'Quigley, J.2
  • 17
    • 0026725698 scopus 로고
    • Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer
    • O'Quigley, J. (1992) Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer. Biometrics, 48, 853-862.
    • (1992) Biometrics , vol.48 , pp. 853-862
    • O'Quigley, J.1
  • 18
    • 0025148278 scopus 로고
    • Continual reassessment method: A practical design for phase I clinical trials in cancer
    • O'Quigley, J., Pepe, M., Fisher, L. (1990) Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics, 46, 33-48.
    • (1990) Biometrics , vol.46 , pp. 33-48
    • O'Quigley, J.1    Pepe, M.2    Fisher, L.3
  • 19
    • 0025986460 scopus 로고
    • Methods for dose finding studies in cancer clinical trials: A review and results of a Monte Carlo study
    • O'Quigley, J. and Chevret, S. (1991) Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study. Stat. in Med., 10, 1647-1664.
    • (1991) Stat. in Med , vol.10 , pp. 1647-1664
    • O'Quigley, J.1    Chevret, S.2
  • 20
    • 0029938415 scopus 로고    scopus 로고
    • Continual reassessment method: A likelihood approach
    • O'Quigley, J. and Shen L.Z. (1996) Continual reassessment method: a likelihood approach. Biometrics, 52, 163-174.
    • (1996) Biometrics , vol.52 , pp. 163-174
    • O'Quigley, J.1    Shen, L.Z.2
  • 21
    • 0000589197 scopus 로고    scopus 로고
    • A stopping rule for the continual reassessment method
    • O'Quigley, J. and Reiner E., (1998) A stopping rule for the continual reassessment method. Biometrika, 85, 741-18.
    • (1998) Biometrika , vol.85 , pp. 741-718
    • O'Quigley, J.1    Reiner, E.2
  • 22
    • 0033619523 scopus 로고    scopus 로고
    • Another look at two phase I clinical trial designs (with commentary)
    • O'Quigley, J. (1999) Another look at two phase I clinical trial designs (with commentary). Stat. in Med., 18, 2683-92.
    • (1999) Stat. in Med , vol.18 , pp. 2683-2692
    • O'Quigley, J.1
  • 23
  • 24
    • 0035186085 scopus 로고    scopus 로고
    • Dose finding designs for HIV studies
    • O'Quigley, J., Hughes, M., and Fenton, T. (2001) Dose finding designs for HIV studies. Biometrics 57, 1018-29.
    • (2001) Biometrics , vol.57 , pp. 1018-1029
    • O'Quigley, J.1    Hughes, M.2    Fenton, T.3
  • 25
    • 1142304984 scopus 로고    scopus 로고
    • Non-parametric optimal design in dose finding studies
    • O'Quigley J., Paoletti, X., and Maccario, J. (2002) Non-parametric optimal design in dose finding studies. Biostatics 3, 51-56.
    • (2002) Biostatics , vol.3 , pp. 51-56
    • O'Quigley, J.1    Paoletti, X.2    Maccario, J.3
  • 27
    • 0029780751 scopus 로고    scopus 로고
    • Improved designs for dose escalation studies using pharmacokinetic measurements
    • Piantadosi, S. and Liu, G. (1996) Improved designs for dose escalation studies using pharmacokinetic measurements. Stat. in Med., 15, 1605-18.
    • (1996) Stat. in Med , vol.15 , pp. 1605-1618
    • Piantadosi, S.1    Liu, G.2
  • 28
    • 0032648126 scopus 로고    scopus 로고
    • Operating characteristics of the standard phase I clinical trial design
    • Reiner E., Paoletti, X., and O'Quigley (1998) Operating characteristics of the standard phase I clinical trial design. Comp. Statist. and Data Anal., 30, 303-315.
    • (1998) Comp. Statist. and Data Anal , vol.30 , pp. 303-315
    • Reiner, E.1    Paoletti, X.2    O'Quigley3
  • 29
    • 0000016172 scopus 로고
    • A stochastic approximation method
    • Robbins, H. and Monro, S. (1951) A stochastic approximation method. Annals of Math. Stat., 29, 351-56.
    • (1951) Annals of Math. Stat , vol.29 , pp. 351-356
    • Robbins, H.1    Monro, S.2
  • 30
    • 33746402001 scopus 로고    scopus 로고
    • Consistency of continual reassessment method in dose finding studies
    • Shen, L.Z. and O'Quigley, J. (1996) Consistency of continual reassessment method in dose finding studies. Biometrika, 83, 395-406.
    • (1996) Biometrika , vol.83 , pp. 395-406
    • Shen, L.Z.1    O'Quigley, J.2
  • 32
    • 0000950512 scopus 로고
    • On the existence of maximum likelihood estimators for the binomial response models
    • Silvapulle, M.J. (1981) On the existence of maximum likelihood estimators for the binomial response models. J.R. Stat. Soc. B, 43, 310-313.
    • (1981) J.R. Stat. Soc. B , vol.43 , pp. 310-313
    • Silvapulle, M.J.1
  • 33
    • 0024452804 scopus 로고
    • Design and analysis of phase I clinical trials
    • Storer, B.E. (1989) Design and analysis of phase I clinical trials. Biometrics, 45, 925-937.
    • (1989) Biometrics , vol.45 , pp. 925-937
    • Storer, B.E.1
  • 34
    • 0027745947 scopus 로고
    • Small-sample confidence sets for the MTD in a phase I clinical trial
    • Storer, B.E. (1993) Small-sample confidence sets for the MTD in a phase I clinical trial. Biometrics, 49, 1117-25.
    • (1993) Biometrics , vol.49 , pp. 1117-1125
    • Storer, B.E.1
  • 36
    • 0031670630 scopus 로고    scopus 로고
    • Bayesian decision procedures based on logistic regression models for dose-finding studies
    • Whitehead, J. and Williamson, D. (1998) Bayesian decision procedures based on logistic regression models for dose-finding studies. J. Biopharm. Stat., 8, 445-67.
    • (1998) J. Biopharm. Stat , vol.8 , pp. 445-467
    • Whitehead, J.1    Williamson, D.2
  • 37
    • 84950861150 scopus 로고
    • Efficient sequential designs with binary data
    • Wu, C.F.J. (1985) Efficient sequential designs with binary data, J. Amer. Stat. Assoc., 80, 974-984.
    • (1985) J. Amer. Stat. Assoc , vol.80 , pp. 974-984
    • Wu, C.F.J.1
  • 38
    • 0000144634 scopus 로고
    • Maximum likelihood recursion and stochastic approximation in sequential designs
    • ed. J. van Ryzin, Institute of Mathematical Statistics Monograph 8, Hayward, CA: Institute of Mathematical Statistics
    • Wu, C.F.J. (1986) Maximum likelihood recursion and stochastic approximation in sequential designs, in Adaptive Statistical Procedures and Related Topics, ed. J. van Ryzin, Institute of Mathematical Statistics Monograph 8, Hayward, CA: Institute of Mathematical Statistics, 298-313.
    • (1986) Adaptive Statistical Procedures and Related Topics , pp. 298-313
    • Wu, C.F.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.